» Authors » Florian Haag

Florian Haag

Explore the profile of Florian Haag including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 18
Citations 42
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Sturm R, Haag F, Bergmann C, Marzi I, Relja B
Eur J Trauma Emerg Surg . 2025 Jan; 51(1):87. PMID: 39870931
Objective: Global per capita alcohol consumption is increasing, posing significant socioeconomic and medical challenges also due to alcohol-related traumatic injuries but also its biological effects. Trauma as a leading cause...
2.
Haag F, Gylstorff S, Bujok J, Pech M, Relja B
Cancers (Basel) . 2024 Aug; 16(16). PMID: 39199602
Purpose: Hepatocellular carcinoma (HCC) is the largest subgroup of primary liver tumors. Ablative therapies, such as selective internal radiation therapy (SIRT), are used in late stages for patients with unresectable...
3.
Pietsch F, Haag F, Ayx I, Grawe F, Vellala A, Schoenberg S, et al.
Abdom Radiol (NY) . 2024 Aug; 49(12):4295-4306. PMID: 39115682
Purpose: Tumoral heterogeneity poses a challenge for personalized cancer treatments. Especially in metastasized cancer, it remains a major limitation for successful targeted therapy, often leading to drug resistance due to...
4.
Vellala A, Mogler C, Haag F, Tollens F, Rudolf H, Pietsch F, et al.
Front Med (Lausanne) . 2024 Jun; 11:1407235. PMID: 38903806
Purpose: This study compares phantom-based variability of extracted radiomics features from scans on a photon counting CT (PCCT) and an experimental animal PET/CT-scanner (Albira II) to investigate the potential of...
5.
Haag F, Emmrich S, Hertel A, Rink J, Norenberg D, Schoenberg S, et al.
Diagnostics (Basel) . 2024 Jun; 14(11). PMID: 38893656
The clinical use of photon-counting CT (PCCT) allows for the generation of virtual non-contrast (VNC) series from contrast-enhanced images. In routine clinical practice, specific issues such as ruling out acute...
6.
Haag F, Grosse Hokamp N, Overhoff D, Dasegowda G, Kuru M, Norenberg D, et al.
Eur J Radiol . 2024 Apr; 175:111448. PMID: 38574510
Purpose: Aim of the recent study is to point out a method to optimize quality of CT scans in oncological patients with port systems. This study investigates the potential of...
7.
Haag F, Hertel A, Tharmaseelan H, Kuru M, Haselmann V, Brochhausen C, et al.
Rofo . 2023 Dec; 196(3):e1. PMID: 38154465
No abstract available.
8.
Haag F, Hertel A, Tharmaseelan H, Kuru M, Haselmann V, Brochhausen C, et al.
Rofo . 2023 Nov; 196(3):262-272. PMID: 37944935
With personalized tumor therapy, understanding and addressing the heterogeneity of malignant tumors is becoming increasingly important. Heterogeneity can be found within one lesion (intralesional) and between several tumor lesions emerging...
9.
Gylstorff S, Wilke V, Kraft D, Bertrand J, Pech M, Haag F, et al.
Int J Mol Sci . 2023 Aug; 24(15). PMID: 37569887
Incidence of hepatocellular carcinoma (HCC) is increasing globally. Radioembolization (RE)/selective internal radiotherapy (SIRT) is a promising treatment for inoperable HCC. RE triggers an immune response, involving extracellular vesicles (EVs) which...
10.
Schnitzer M, von Munchhausen N, Biechele G, Runtemund J, Grawe F, Geyer T, et al.
Front Oncol . 2023 Aug; 13:1161738. PMID: 37554160
Objectives: Colorectal cancer (CRC) is a serious challenge for the health system. In 2022 CRC represented 8% of cancer diagnoses in the United States. 30% of patients already show metastases...